ADL Passes EPCS Re-Certification

ADL Data Passes DEA EPCS Re-Certification The re-certification extends authorization to use DEA EPCS Certificates for another two years and allows physicians to use their Smartphone to comply with the required 2-Factor Authentication. This eliminates the need to carry a separate FOB or Id Cards. A copy of the report has been posted on the ADL Website: EMR Certifications. Approved Certification Process: //www.deadiversion.usdoj.gov/ecomm/e_rx/thirdparty.htm Verify Physicians DEA Registration:…

Read More

Auto-select ICD-10 Diagnosis Codes in ADL Order Entry

Enhanced ICD-10 Diagnosis Codes Accessibility Medication and lab orders in ADL will now display the most commonly used ICD-10 codes, based on the type of order. Upon entering an order into the system, prescribers will be prompted to choose from a list of the most appropriate ICD-10 codes, based on the medication or lab that they are ordering. Users will then select one of the available options or will be able to enter a code…

Read More

ADL Testing PDPM/MDS Changes

Patient Driven Payment Model (PDPM) MDS Changes CMS has provided a beta version of the PDPM calculator for the MDS. The calculator has been integrated into the MDS and is being test for early release. The screen has been simplified to provide a easier view. Preview of the MDS RAI screen:    …

Read More

EMR Updates for CMS New Patient Driven Payment Module (PDPM)

Announcing Major Functionality Enhancements to ADL Optimum Series EMR ADL is enhancing its software in preparation for the Patient Driven Payment Module (PDPM). Our goal is to assist facility staff in classifying patients into the appropriate payment groups based on data driven clinical characteristics. PDPM is value based and rewards patient outcomes. Patient Driven Payment Method (PDPM) Information Effective October 01, 2019, each patient will be assigned a case mix classification that drives reimbursement.

Read More

Hazardous Medications Alerts have been Added to OE & eMAR

Alerts have been added to the Order Entry and the eMAR applications For the proposed 2018 list, the National Institute for Occupational Safety and Health (NIOSH) presents the policy for how drugs are assigned to the 3 hazardous drug classifications using a new peer reviewed 5 Category system based on evidence of the hazard: Category 1—Special Handling Information Category 2—Insufficient Toxicity Information Available to Meet NIOSH Definition of Hazardous Drug Category 3—Available Information Shows a…

Read More